Long-term study to collect additional information to evaluate the saftey and tolerability of BAY 63-2521 in different doses

Update Il y a 4 ans
Reference: EUCTR2006-003520-10

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To investigate the safety, tolerability, and feasibility of individual titration of BAY 63 2521 according to peripheral systolic blood pressure. In addition, long term safety and tolerability of BAY 63 2521 should be investigated during the Optional Open Label Extension Period


Inclusion criteria

  • Subjects with PH due to
  • • Pulmonary arterial hypertension (PAH) [Venice protocol] or
  • • Chronic thrombembolic PH (CTEPH)

Links